MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-23-0090637
Ario Pharma Private Limited - pharma in Kalyan, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹38.14 Lakh
▲ 11% YoY
Net loss · FY 2025
₹5.22 Lakh
Net margin -13.7%
EBITDA · FY 2025
₹1.19 Lakh
EBITDA margin 3.1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹22 Lakh
Secured borrowings
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
About Ario Pharma Private Limited
Data last updated:
Ario Pharma Private Limited is a private limited company based in Kalyan, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 March 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2018PTC306090. Its GSTIN is 27AAQCA6083Q1ZQ (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Archis Vinayak Nerlikar and Bhavna Archis Nerlikar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kalyan, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹38.14 Lakh, a growth of 11% compared to the previous year. For the same year it recorded a net loss of ₹5.22 Lakh (net margin -13.7%) and EBITDA of ₹1.19 Lakh (EBITDA margin 3.1%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years.
As per MCA filings, the company has open charges of ₹22 Lakh on record.
Ario Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-23-0090637). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ariopharma.in.
Company details
CIN U24304MH2018PTC306090
Registration Number 306090
Incorporation Date 08 March 2018
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-23-0090637
Recognitions & Rankings of Ario Pharma
Contact details
Ario Pharma Private Limited's registered office is in Kalyan, Maharashtra. Its website is ariopharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressF – 907 Orchid Wing – N Codename Golden Dream, Sector – 10 Off. Taloja MIDC Road, Kalyan, Maharashtra, India – 421204
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ario Pharma Private Limited, buy the company report.
Comprehensive company report
Ario Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Ario Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ario Pharma Private Limited, buy the company report.
Financials of Ario Pharma Private Limited
FY 2025 filings availableArio Pharma Private Limited reported revenue of ₹38.14 Lakh (up 11% YoY) for FY 2025.
Revenue · FY 2025
₹38.14 Lakh ▲ 11%
Net loss · FY 2025
₹5.22 Lakh margin -13.7%
EBITDA · FY 2025
₹1.19 Lakh margin 3.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▼ 9%
EBITDA CAGR growth
3 years · compounded
▼ 11%
Revenue rose 11% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 9%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.19 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5.22 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.1% | ||||
| Net Profit Margin | -13.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ario Pharma Private Limited, buy the company report.
Board of directors of Ario Pharma Private Limited
Ario Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Archis Vinayak Nerlikar Also directs: Nerlikar Hospitals Private Limited | Director | 08 Mar 2018 | 8 Years 8 Months | Current |
| Bhavna Archis Nerlikar Also directs: Nerlikar Hospitals Private Limited | Director | 27 Mar 2020 | 6 Years 7 Months | Current |
Peer comparison
Ario Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| GLS Propmart Private Limited | ₹38.15 Lakh (FY 2025) | 8.0% | Ghaziabad, Uttar Pradesh, India | |||
| Cherubic Laboratories Private Limited | ₹38.15 Lakh (FY 2024) | 37.0% | Cuttack, Odisha, India | |||
| Apurva Barter Pvt Ltd | ₹38.15 Lakh (FY 2024) | -88.0% | Kolkata, West Bengal, India | |||
| Hello Art and Design Private Limited | ₹38.14 Lakh (FY 2025) | 353.0% | Mumbai, Maharashtra, India | |||
| S. B. Marine Products Limited | ₹38.14 Lakh (FY 2025) | 5.0% | Guwahati, Assam, India | |||
| Ario Pharma Private Limitedthis company | ₹38.14 Lakh (FY 2025) | -₹5.22 Lakh | -13.7% | 11.0% | Kalyan, Maharashtra, India | |
| Maximum Financial Advisory Private Limited | ₹38.14 Lakh (FY 2023) | 45.0% | Kolkata, West Bengal, India | |||
| Sudeco (India) Private Limited | ₹38.14 Lakh (FY 2024) | -62.0% | Mumbai, Maharashtra, India | |||
| U-Turn International Private Limited | ₹38.14 Lakh (FY 2022) | -92.0% | Rajkot, Gujarat, India | |||
| NMG Management Private Limited | ₹38.14 Lakh (FY 2024) | 7.0% | Bhubaneswar, Odisha, India | |||
| Essilor Remedies Private Limited | ₹38.13 Lakh (FY 2025) | 17.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Ario Pharma Private Limited, buy the company report.
Auditor
Ario Pharma Private Limited is audited by M H JOSHI & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M H JOSHI & CO | FY 2022 | 104408W |
Shareholding
The shareholding of Ario Pharma Private Limited is on record for 4 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Ario Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹22 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Jun 2022 | 100593552 | Tata Capital Housing Finance Limited | ₹22 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Ario Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ario Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ario Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAQCA6083Q1ZQ | Maharashtra | Active | 08 Sep 2020 |
To see the full GST registrations and return filing status of Ario Pharma Private Limited, buy the company report.
Recent activity
Ario Pharma Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Jitendra Atmaram Samant ceased to be Director on 28 Mar 2020.
AGM
Ario Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ario Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Charges
A charge with Tata Capital Housing Finance Limited amounted to Rs. 22.00 Lakh with Charge ID 100593552 was registered on 09 Jun 2022.
Ceased
Jitendra Atmaram Samant ceased to be Director.
Appointed
Bhavna Archis Nerlikar was appointed as Director.
Appointed
Archis Vinayak Nerlikar was appointed as Director.
Incorporation
08 Mar 2018
Ario Pharma Private Limited was registered on 08 Mar 2018 with Roc Mumbai Ii & aged 8 years 8 months as per MCA records.
Frequently asked questions
Ario Pharma is an active private limited company based in Kalyan, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 March 2018 (8+ years old) and is registered under CIN U24304MH2018PTC306090.
Ario Pharma has 2 current directors:
- Archis Vinayak Nerlikar - Director
- Bhavna Archis Nerlikar - Director
The latest financial statements of Ario Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Ario Pharma is 27AAQCA6083Q1ZQ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Ario Pharma is U24304MH2018PTC306090. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ario Pharma was incorporated on 08 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Ario Pharma by revenue are GLS Propmart Private Limited, Cherubic Laboratories Private Limited, Apurva Barter Pvt Ltd, Hello Art and Design Private Limited, S. B. Marine Products Limited and 5 more, all in the same principal business activity (wholesale trading).
Jitendra Atmaram Samant ceased to be Director on 28 Mar 2020. Bhavna Archis Nerlikar was appointed as Director on 27 Mar 2020. Archis Vinayak Nerlikar was appointed as Director on 08 Mar 2018.
Yes, Ario Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-23-0090637).
Ario Pharma can be reached through the website ariopharma.in. Its registered office is in Kalyan, Maharashtra, India.
The registered office of Ario Pharma is at F – 907 Orchid Wing – N Codename Golden Dream, Sector – 10 Off. Taloja MIDC Road, Kalyan, Maharashtra, India – 421204.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages